diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inact.) and haemophilus type b conjugate vaccine (adsorbed)
Лекарствени продукти, съдържащи diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inact.) and haemophilus type b conjugate vaccine (adsorbed)
| Търговско име | Концентрация | Производител |
|---|---|---|
| Hexacima | --¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺) | Sanofi Winthrop Industrie |
| Hexyon | --¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺) | Sanofi Winthrop Industrie |
| Vaxelis | --¹ One dose (0.5 ml) contains: Diphtheria Toxoid¹: 15 Lf (≥ 20 IU)⁶ Tetanus Toxoid¹: 5 Lf (≥ 40 IU)⁶ Bordetella pertussis antigens¹: Pertussis Toxoid (PT) 20 micrograms Filamentous Haemagglutinin (FHA) 20 micrograms Pertactin (PRN) 3 micrograms Fimbriae Types 2 and 3 (FIM) 5 micrograms Hepatitis B surface antigen²,³: 10 micrograms Poliovirus (Inactivated)⁴: Type 1 (Mahoney) 29 D antigen units⁵ Type 2 (MEF-1) 7 D antigen units⁵ Type 3 (Saukett) 26 D antigen units⁵ Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) 3 micrograms Conjugated to meningococcal protein² 50 micrograms ¹ adsorbed on aluminium phosphate (0.17 mg Al³⁺) ² adsorbed on amorphous aluminium hydroxyphosphate sulfate (0.15 mg Al³⁺) ³ produced in yeast (Saccharomyces cerevisiae) cells by recombinant DNA technology ⁴ produced in Vero cells ⁵ These antigen quantities are strictly the same as those previously expressed as 40-8-32 D-antigen units, for virus type 1, 2 and 3 respectively, when measured by another suitable immunochemical method ⁶ or equivalent activity determined by an immunogenicity or antigenicity evaluation. | MCM Vaccine B.V. |